Ken Griffin Neuronetics, Inc. Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Neuronetics, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 30,100 shares of STIM stock, worth $28,294. This represents 0.0% of its overall portfolio holdings.

Number of Shares

30,100

Previous 3,800 692.11%

Holding current value

$28,294

Previous $6,000 266.67%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.73 - $4.81 $22,081 - $61,394	12,764 Added 13.96%	104,173 $187,000
Q1 2024 May 15, 2024	BUY	$2.68 - $4.8 $25,347 - $45,398	9,458 Added 11.54%	91,409 $435,000
Q4 2023 Feb 14, 2024	SELL	$1.05 - $2.9 $116,156 - $320,812	-110,625 Reduced 57.44%	81,951 $237,000
Q3 2023 Nov 14, 2023	SELL	$1.29 - $2.22 $62,574 - $107,685	-48,507 Reduced 20.12%	192,576 $259,000
Q2 2023 Aug 14, 2023	BUY	$2.07 - $2.92 $160,408 - $226,276	77,492 Added 47.37%	241,083 $518,000
Q1 2023 May 15, 2023	BUY	$2.81 - $6.71 $441,012 - $1.05 Million	156,944 Added 2361.13%	163,591 $476,000
Q4 2022 Feb 14, 2023	SELL	$2.74 - $6.87 $79,755 - $199,971	-29,108 Reduced 81.41%	6,647 $45,000
Q3 2022 Nov 14, 2022	SELL	$2.35 - $4.66 $144,332 - $286,207	-61,418 Reduced 63.2%	35,755 $113,000
Q2 2022 Aug 15, 2022	BUY	$2.09 - $3.71 $93,034 - $165,146	44,514 Added 84.53%	97,173 $312,000
Q1 2022 May 16, 2022	BUY	$2.84 - $4.52 $113,503 - $180,646	39,966 Added 314.87%	52,659 $160,000
Q3 2021 Nov 15, 2021	SELL	$6.22 - $15.54 $194,642 - $486,293	-31,293 Reduced 71.14%	12,693 $83,000
Q2 2021 Aug 16, 2021	SELL	$10.15 - $17.25 $400,914 - $681,357	-39,499 Reduced 47.31%	43,986 $704,000
Q1 2021 May 17, 2021	BUY	$10.6 - $21.27 $695,137 - $1.39 Million	65,579 Added 366.24%	83,485 $1.03 Million
Q4 2020 Feb 16, 2021	SELL	$4.95 - $11.45 $13,181 - $30,491	-2,663 Reduced 12.95%	17,906 $199,000
Q3 2020 Nov 16, 2020	BUY	$1.82 - $5.87 $37,435 - $120,740	20,569 New	20,569 $100,000
Q1 2020 May 15, 2020	SELL	$1.28 - $4.5 $27,312 - $96,021	-21,338 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$4.03 - $9.22 $23,180 - $53,033	5,752 Added 36.9%	21,338 $96,000
Q3 2019 Nov 14, 2019	BUY	$8.31 - $13.03 $19,711 - $30,907	2,372 Added 17.95%	15,586 $129,000
Q2 2019 Aug 14, 2019	SELL	$9.0 - $17.2 $83,241 - $159,082	-9,249 Reduced 41.17%	13,214 $165,000
Q1 2019 May 15, 2019	BUY	$13.6 - $19.58 $142,201 - $204,728	10,456 Added 87.08%	22,463 $0
Q4 2018 Feb 14, 2019	BUY	$16.0 - $31.84 $19,808 - $39,417	1,238 Added 11.5%	12,007 $232,000
Q3 2018 Nov 13, 2018	SELL	$24.32 - $37.54 $48,056 - $74,179	-1,976 Reduced 15.5%	10,769 $0
Q2 2018 Aug 10, 2018	BUY	$26.61 - $27.78 $339,144 - $354,056	12,745 New	12,745 $0

Others Institutions Holding STIM

# of Institutions

Shares Held

13.1M

Call Options Held

30.1K

Put Options Held

View Full List

About Neuronetics, Inc.

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $25.4M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

More about STIM

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account